Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

2018

Background Treatment choice in multiple sclerosis (MS) is crucial for optimizing risk–benefit profile.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

28

References

9

Citations